Eledon Pharmaceuticals (ELDN) Change in Account Payables (2013 - 2017)
Eledon Pharmaceuticals posted quarterly Change in Account Payables of -$154000.0 for Q1 2017, down 122.71% year-on-year from $678000.0 in Q1 2016, and up 66.23% on a QoQ basis from -$456000.0 in Q4 2016.
Eledon Pharmaceuticals (ELDN) has 5 years of Change in Account Payables data on file, last reported at -$154000.0 in Q1 2017.
- For the quarter ending Q1 2017, Change in Account Payables fell 122.71% year-over-year to -$154000.0; the trailing twelve-month figure through Mar 2017 stood at -$1.6 million (down 4.01% YoY), and the FY2016 full-year result was -$778000.0, down 275.62% from the prior year.
- Change in Account Payables for Q1 2017 stood at -$154000.0, up from -$456000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.7 million in Q1 2015 and bottomed at -$1.8 million in Q2 2015.
- The 5-year median for Change in Account Payables is -$222500.0 (2014), against an average of -$46785.7.
- The widest annual swing landed in 2015, when Change in Account Payables soared 234.46%; it then plunged 5233.33% in 2016.
- A 5-year view of Change in Account Payables shows it stood at -$926000.0 in 2013, then decreased by 21.38% to -$1.1 million in 2014, then jumped by 60.5% to -$444000.0 in 2015, then decreased by 2.7% to -$456000.0 in 2016, then jumped by 66.23% to -$154000.0 in 2017.
- The last three Change in Account Payables figures came in at -$154000.0 (Q1 2017), -$456000.0 (Q4 2016), and -$960000.0 (Q3 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -154,000.00 |
| Mar 31, 2017 | -154,000.00 |
| Dec 31, 2016 | -456,000.00 |
| Dec 31, 2016 | -456,000.00 |
| Sep 30, 2016 | -960,000.00 |
| Sep 30, 2016 | -960,000.00 |
| Jun 30, 2016 | -40,000.00 |
| Jun 30, 2016 | -40,000.00 |
| Mar 31, 2016 | 678,000.00 |
| Mar 31, 2016 | 678,000.00 |
| Dec 31, 2015 | -444,000.00 |
| Dec 31, 2015 | -444,000.00 |
| Sep 30, 2015 | -18,000.00 |
| Sep 30, 2015 | -18,000.00 |
| Jun 30, 2015 | -1.76 Mn |
| Jun 30, 2015 | -1.76 Mn |
| Mar 31, 2015 | 2.67 Mn |
| Mar 31, 2015 | 2.67 Mn |
| Dec 31, 2014 | -1.12 Mn |
| Dec 31, 2014 | -1.12 Mn |
| Sep 30, 2014 | 1.38 Mn |
| Sep 30, 2014 | 1.38 Mn |
| Jun 30, 2014 | -291,000.00 |
| Jun 30, 2014 | -291,000.00 |
| Mar 31, 2014 | 798,000.00 |
| Mar 31, 2014 | 798,000.00 |
| Dec 31, 2013 | -926,000.00 |
| Dec 31, 2013 | -926,000.00 |